REQUEST A DEMO
Total
USD $0.00
Search more companies

Confar Pharma LTD (Конфар Фарма ЕООД) (Bulgaria)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Confar Pharma LTD Profile Updated: February 16, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Confar Pharma LTD (Конфар Фарма ЕООД) is a company in Bulgaria, with a head office in Sofia. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on October 28, 2026. Confar Pharma LTD (Конфар Фарма ЕООД) currently employs 1 (2024) people. From the latest financial highlights, Confar Pharma LTD (Конфар Фарма ЕООД) reported a net sales revenue increase of 1036.55% in 2023. Its total assets grew by 492.07% over the same period.

Headquarters
Mladost 4, Bl. 621, Vh. 1, ET. 4
Sofia; Sofia - city; Postal Code: 1766

Contact Details: Purchase the Confar Pharma LTD (Конфар Фарма ЕООД) report to view the information.

Basic Information
Total Employees:
Purchase the Confar Pharma LTD (Конфар Фарма ЕООД) report to view the information.
Registered Capital:
Purchase the Confar Pharma LTD (Конфар Фарма ЕООД) report to view the information.
Financial Auditors:
Purchase the Confar Pharma LTD (Конфар Фарма ЕООД) report to view the information.
Incorporation Date:
October 28, 2026
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Confar Pharma LTD (Конфар Фарма ЕООД) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
1036.55%▲
Total Operating Revenue
1037.08%▲
Operating Profit
-98.52%▼
EBITDA
-72.34%▼
Net Profit/Loss for the Period
N/A
Total Assets
492.07%▲
Total Equity
-11.59%▼
Operating Profit Margin
-35.2%▼
Net Profit Margin
N/A
Return on Equity (ROE)
N/A

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?